Equity, Diversity, & Inclusion Committee

The main function of the Equity, Diversity and Inclusion (EDI) Committee is to monitor and report on the progress of the BioCanRx EDI Action Plan. The committee will act in an advisory capacity to the BioCanRx Board of Directors with respect to EDI matters. The EDI Committee includes two members of BioCanRx’s Board of Directors, and three members external to the Board who are experts in the area of equity, diversity and inclusion related to the science academic sector.

Members of the committee

Dr. Tina Gruosso (She/Her) Chair Scientist, Forbius	Gillian Carleton (They/Them) PhD Student, University of Victoria	Aaron Prosper (He/Him) Project Manager, Nova Scotia Mi’kmaw Nation Cancer Care Strategy Graduate Student, University of Prince Edward Island	Dr. John Stagg (He/Him) Associate Professor, Faculty of Pharmacy at the University of Montreal Lab Head at the CHUM Hospital Research Centre
Debra Lynkowski Chief Operating Officer The Ottawa Hospital Research Institute

BioCanRx Staff

Dr. Stéphanie Michaud, President and Chief Executive Officer	Dr. Megan Mahoney, Director, Scientific Affairs and Training Programs	Ms. Laurie Cameron, Manager, Knowledge Mobilization & Corporate Operations

Observer